Skip to content

Clinical trials

Phase 1/2 Carcinoma, Squamous Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 1/2 Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20083
20103
20132
20141
20162
20174
20186
20195
20205
20211
20234
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting8
Unknown status7
Terminated6
Not yet recruiting3
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Advaxis, Inc.1
AstraZeneca1
Azienda Ospedaliero-Universitaria Careggi1
BPGbio1
Bruce Robinson, MD1
Cascadian Therapeutics Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell46
Squamous Cell Carcinoma of Head and Neck19
Carcinoma, Non-Small-Cell Lung11
Head and Neck Neoplasms11
Carcinoma9
Neoplasms7
Melanoma6
Carcinoma, Renal Cell5
Colorectal Neoplasms5
Oropharyngeal Neoplasms5

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.